More on ABVX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $15.86 |
|
|||
| Open | $16.08 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $16.12 | ||||
| Day Low | $15.89 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 7,484 | ||||
- Form SC 13G Abivax S.A. Filed by: TCG Crossover GP I, LLC
- Abivax (ABVX) PT Raised to $16 at Morgan Stanley
- Form 20-F Abivax S.A. For: Dec 31
- Form 6-K Abivax S.A. For: Apr 02
- Sofinnova Investments Appoints Troy Ignelzi as Executive Advisor
- Form SC 13G/A Abivax S.A. Filed by: Venrock Healthcare Capital Partners III, L.P.
- Abivax Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Sponsorship of Scientific Symposium at The 19th Congress of European Crohn’s and Colitis Organization (ECCO)
- BariaTek Medical Announces the First-in-Human Implantation of Its BariTon™ Device, a Non-Surgical Gastro-Intestinal Medical Device Aiming to Replicate the Efficacy of Obesity Surgery Without the Inv
- Form 6-K Abivax S.A. For: Feb 02
- Form 6-K Abivax S.A. For: Jan 22
Entities mentioned with ABVX
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- IPO | View Related Stories »
- AdCom | View Related Stories »
- RBC Capital | View Related Stories »
- 13G | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
